AUA 2016 - Renal Cancer

REVIEW UroToday

Viewing 1-15 of 15 articles

AUA 2016: Medical Risk Factors For Chronic Kidney Disease In Patients With Normal Baseline Kidney Function are Not Independent Predictors Of Worse Renal Function Outcomes Following Robotic Partial Nephrectomy - Poster Session Highlights

AUA 2016: Body Mass Index (BMI) and the clinico-pathological characteristics of localized renal masses – an international multi-institutional study. - Poster Session Highlights

AUA 2016: Could perirenal fat be more important than the tumor itself? The MAP score better predicts perioperative morbidity than the RENAL score. - Session Highlights

AUA 2016: A Comprehensive Competing Risk Calculator For Patients With Cortical Renal Masses Treatment Selection - Poster Session Highlights

AUA 2016: IB-lymphocytes differentiation is atypical in clear cell renal cell carcinoma (ccRCC) and low preoperative B-cell count is associated with poor cancer specific survival (CSS). - Poster Session Highlights

AUA 2016: Impact of lymph node dissection at the time of radical nephrectomy and tumor thrombectomy on oncological outcomes of patients with renal cell carcinoma and tumor thrombus - Poster Session Highlights

AUA 2016: Differences in Overall Survival for Patients with Stage I-II Renal Cell Carcinoma Treated with Partial or Radical Nephrectomy - Session Highlights

AUA 2016: Relationship of Post-operative Chronic Kidney Disease Subtype Status and Outcomes in Patients Undergoing Renal Surgery - Session Highlights

AUA 2016: Optimization of Surveillance Following Nephrectomy for RCC? - Session Highlights

AUA 2016: Novel Imaging Modalities for the Solid Renal Mass: Are We Ready for a Radiographic Biopsy? SUO Session Highlights

AUA 2016: Optimizing Patient Selection for Cytoreductive Nephrectomy in the Targeted Therapy Era - Session Highlights

AUA 2016: Reporting Standards of Indeterminate Renal Masses on CT and MRI: A National Survey of Urologists and Radiologists by the Society of Abdominal Radiology RCC Disease-Focused Panel - Session Highlights

AUA 2016: Identifying mRCC Patients with Venous Thrombus Who Are Likely to Benefit from Cytoreductive Surgery - Session Highlights

AUA 2016: Renal function before and after cytoreductive nephrectomy in a phase 3 randomized clinical trial - Session Highlights

AUA 2016: Neoadjuvant approaches to RCC perioperative immunotherapy - Session Highlights